Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety & Efficacy of IV Acetaminophen in Pediatric Inpatients
NCT00598702Phase 3Completed
- Sponsor
- Mallinckrodt Pharmaceuticals
- Start
- Jan 2008
- Primary completion
- Dec 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of acetaminophen in pain and fever, sponsored by Mallinckrodt Pharmaceuticals. Primary endpoints: Number of Subjects Reporting at Least One Treatment Emergent Adverse Event and Number of Subjects Reporting at Least One Serious Treatment Emergent Adverse Event. Started Jan 2008; status: completed.
02
Drugs
acetaminophen
03
Conditions
painfever
Beyond the preview
Go deeper on NCT00598702.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00598702.